These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

952 related items for PubMed ID: 22534830

  • 1. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses.
    Drzezga A, Souvatzoglou M, Eiber M, Beer AJ, Fürst S, Martinez-Möller A, Nekolla SG, Ziegler S, Ganter C, Rummeny EJ, Schwaiger M.
    J Nucl Med; 2012 Jun; 53(6):845-55. PubMed ID: 22534830
    [Abstract] [Full Text] [Related]

  • 2. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH, von Gall C, Zeilinger M, Wiesmüller M, Braun H, Ziegler S, Kuwert T, Uder M, Dörfler A, Kalender WA, Lell M.
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
    Gaertner FC, Beer AJ, Souvatzoglou M, Eiber M, Fürst S, Ziegler SI, Brohl F, Schwaiger M, Scheidhauer K.
    Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
    [Abstract] [Full Text] [Related]

  • 4. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L, Nicolai E, Luongo A, Aiello M, Catalano OA, Soricelli A, Salvatore M.
    Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
    [Abstract] [Full Text] [Related]

  • 5. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M, Takei T, Souvatzoglou M, Mayerhoefer ME, Fürst S, Gaertner FC, Loeffelbein DJ, Rummeny EJ, Ziegler SI, Schwaiger M, Beer AJ.
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [Abstract] [Full Text] [Related]

  • 6. Simulation of a MR-PET protocol for staging of head-and-neck cancer including Dixon MR for attenuation correction.
    Eiber M, Souvatzoglou M, Pickhard A, Loeffelbein DJ, Knopf A, Holzapfel K, Martinez-Möller A, Nekolla SG, Scherer EQ, Schwaiger M, Rummeny EJ, Beer AJ.
    Eur J Radiol; 2012 Oct; 81(10):2658-65. PubMed ID: 22078793
    [Abstract] [Full Text] [Related]

  • 7. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data.
    Martinez-Möller A, Souvatzoglou M, Delso G, Bundschuh RA, Chefd'hotel C, Ziegler SI, Navab N, Schwaiger M, Nekolla SG.
    J Nucl Med; 2009 Apr; 50(4):520-6. PubMed ID: 19289430
    [Abstract] [Full Text] [Related]

  • 8. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
    Heusch P, Buchbender C, Beiderwellen K, Nensa F, Hartung-Knemeyer V, Lauenstein TC, Bockisch A, Forsting M, Antoch G, Heusner TA.
    Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
    [Abstract] [Full Text] [Related]

  • 9. Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system.
    Strobel K, Rüdy M, Treyer V, Veit-Haibach P, Burger C, Hany TF.
    Nucl Med Commun; 2007 Jul; 28(7):555-9. PubMed ID: 17538397
    [Abstract] [Full Text] [Related]

  • 10. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
    Hartung-Knemeyer V, Beiderwellen KJ, Buchbender C, Kuehl H, Lauenstein TC, Bockisch A, Poeppel TD.
    Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
    [Abstract] [Full Text] [Related]

  • 11. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF.
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [Abstract] [Full Text] [Related]

  • 12. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
    Rauscher I, Eiber M, Fürst S, Souvatzoglou M, Nekolla SG, Ziegler SI, Rummeny EJ, Schwaiger M, Beer AJ.
    J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
    [Abstract] [Full Text] [Related]

  • 13. Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer.
    Souvatzoglou M, Eiber M, Takei T, Fürst S, Maurer T, Gaertner F, Geinitz H, Drzezga A, Ziegler S, Nekolla SG, Rummeny EJ, Schwaiger M, Beer AJ.
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1486-99. PubMed ID: 23817684
    [Abstract] [Full Text] [Related]

  • 14. Simultaneous reconstruction of activity and attenuation for PET/MR.
    Salomon A, Goedicke A, Schweizer B, Aach T, Schulz V.
    IEEE Trans Med Imaging; 2011 Mar; 30(3):804-13. PubMed ID: 21118768
    [Abstract] [Full Text] [Related]

  • 15. Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study.
    Halpern BS, Dahlbom M, Auerbach MA, Schiepers C, Fueger BJ, Weber WA, Silverman DH, Ratib O, Czernin J.
    J Nucl Med; 2005 Apr; 46(4):603-7. PubMed ID: 15809482
    [Abstract] [Full Text] [Related]

  • 16. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP, Kramer H, Reiser MF, Glaser C.
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [Abstract] [Full Text] [Related]

  • 17. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J, Ma Q, Guo Q, Sun H, Zhang S, Liu C, Zhai W.
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [Abstract] [Full Text] [Related]

  • 18. Two-dimensional vs three-dimensional imaging in whole body oncologic PET/CT: a Discovery-STE phantom and patient study.
    Bettinardi V, Mancosu P, Danna M, Giovacchini G, Landoni C, Picchio M, Gilardi MC, Savi A, Castiglioni I, Lecchi M, Fazio F.
    Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):214-23. PubMed ID: 17464266
    [Abstract] [Full Text] [Related]

  • 19. Systematic Comparison of the Performance of Integrated Whole-Body PET/MR Imaging to Conventional PET/CT for ¹⁸F-FDG Brain Imaging in Patients Examined for Suspected Dementia.
    Hitz S, Habekost C, Fürst S, Delso G, Förster S, Ziegler S, Nekolla SG, Souvatzoglou M, Beer AJ, Grimmer T, Eiber M, Schwaiger M, Drzezga A.
    J Nucl Med; 2014 Jun; 55(6):923-31. PubMed ID: 24833495
    [Abstract] [Full Text] [Related]

  • 20. Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imaging.
    Brechtel K, Klein M, Vogel M, Mueller M, Aschoff P, Beyer T, Eschmann SM, Bares R, Claussen CD, Pfannenberg AC.
    J Nucl Med; 2006 Mar; 47(3):470-6. PubMed ID: 16513616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.